Identification and characterization of H-2d restricted CD4+ T cell epitopes on Lpp20of Helicobacter pylori

BMC Immunology

Yunshan Ning¹  Shuang Zeng¹  Diandian He¹  Jun Luo³  Lili Zhang²  Yue Xi¹  Yin Jiang¹  Yan Li¹ 

[1] Institute of Biotherapy, School of Biotechnology, Southern Medical University, North1838 Guangzhou Road, Guangzhou 510515, PR China;School of Nursing, Southern Medical University, North1838 Guangzhou Road, Guangzhou, 510515, PR China;Department of Medical Microbiology, School of Public Health and Tropical Disease, Southern Medical University, North1838 Guangzhou Road, Guangzhou, 510515, PR China

关键词: Epitope;    CD4⁺ T cell;    Lpp20;    Helicobacter pylori;   

Others  :  1077857
DOI  :  10.1186/1471-2172-13-68

 received in 2012-04-28, accepted in 2012-11-30,  发布年份 2012

【 摘 要 】

Background

Previous investigation has demonstrated that CD4⁺ T cells play a crucial role in effective immunity against Helicobacter pylori (H.pylori) infection. It has been well proved that Lpp20 is one of major protective antigens that induce immune responses after H.pylori invades host. Therefore it is valuable to identify CD4⁺ T cell epitopes on Lpp20, which is uncharacterized.

Methods

Putative epitopes of H-2^d restricted CD4⁺ T cell on Lpp20 of H.pylori were predicted by the SYFPEITHI algorithm and then eight hypothetical epitope peptides were synthesized. After BALB/c mice were primed with recombinant Lpp20, splenic CD4⁺ T cells were isolated and stimulated with synthesized peptides to measure T cell proliferation and MHC restriction. Cytokine profile was determined by ELISA and real-time PCR. Two identified epitopes were used to immunize mice to investigate CD4⁺ T cell response by flow cytometry.

Results

Two of eight peptides were able to stimulate CD4⁺ T cell proliferation and were mapped to residues 83-97aa and 58-72aa on Lpp20 respectively. These two peptides additively stimulated Th1 cells to secrete IFN-γ.The percentage of CD4⁺ T cell from mice immunized with two identified epitopes respectively was higher than the control group.

Conclusion

The identification and characterization of two CD4⁺ T cell epitopes of Lpp20 helps understand the protective immunity of Lpp20 in H.pylori infection and design effective epitope vaccines against H.pylori.

【 授权许可】

   
2012 Li et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Pappo J, Torrey D, Castriotta L, Savinainen A, Kabok Z, Ibraghimov A: Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 1999, 67(1):337-341.
• [2]Sette A, Fikes J: Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr Opin Immunol 2003, 15(4):461-470.
• [3]Keenan J, Oliaro J, Domigan N, Potter H, Aitken G, Allardyce R, et al.: Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun 2000, 68(6):3337-3343.
• [4]Keenan J, Neal S, Allardyce R, Roake J: Serum-derived IgG1-mediated immune exclusion as a mechanism of protection against H. pylori infection. Vaccine 2002, 20(23–24):2981-2988.
• [5]Kostrzynska M, O’Toole PW, Taylor DE, Trust TJ: Molecular characterization of a conserved 20-kilodalton membrane-associated lipoprotein antigen of Helicobacter pylori. J Bacteriol 1994, 176(19):5938-5948.
• [6]Li Y, Ning YS, Wang YD, Hong YH, Luo J, Dong WQ, et al.: Production of mouse monoclonal antibodies against Helicobacter pylori Lpp 20 and mapping the antigenic epitope by phage display library. J Immunol Methods 2007, 325(1–2):1-8.
• [7]Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50(3–4):213-219.
• [8]Armengol E, Wiesmuller KH, Wienhold D, Buttner M, Pfaff E, Jung G, et al.: Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus. J Gen Virol 2002, 83(Pt 3):551-560.
• [9]Fournel S, Neichel S, Dali H, Farci S, Maillere B, Briand JP, et al.: CD4+ T cells from (New Zealand Black x New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3. J Immunol 2003, 171(2):636-644.
• [10]Sutton P, Wilson J, Kosaka T, Wolowczuk I, Lee A: Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol Cell Biol 2000, 78(1):28-30.
• [11]Gottwein JM, Blanchard TG, Targoni OS, Eisenberg JC, Zagorski BM, Redline RW, et al.: Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund’s adjuvant by systemic immunization. J Infect Dis 2001, 184(3):308-314.
• [12]Drabner B, Reineke U, Schneider-Mergener J, Humphreys RE, Hartmann S, Lucius R: Identification of T helper cell-recognized epitopes in the chitinase of the filarial nematode Onchocerca volvulus. Vaccine 2002, 20(31–32):3685-3694.
• [13]Romagnani S: Th1/Th2 cells. Inflamm Bowel Dis 1999, 5(4):285-294.
• [14]Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, et al.: Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998, 114(3):482-492.
• [15]D’Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, et al.: T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997, 158(2):962-967.
• [16]Mattapallil JJ, Dandekar S, Canfield DR, Solnick JV: A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. Gastroenterology 2000, 118(2):307-315.
• [17]Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, et al.: Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 1999, 67(1):279-285.
• [18]Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD: Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 2000, 165(2):1022-1029.
• [19]Ikewaki J, Nishizono A, Goto T, Fujioka T, Mifune K: Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection. Microbiol Immunol 2000, 44(1):29-39.
• [20]Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ: Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 1997, 113(6):1848-1857.
• [21]Saldinger PF, Porta N, Launois P, Louis JA, Waanders GA, Bouzourene H, et al.: Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 1998, 115(4):891-897.
• [22]Chen M, Chen J, Liao W, Zhu S, Yu J, Leung WK, et al.: Immunization with attenuated Salmonella typhimurium producing catalase in protection against gastric Helicobacter pylori infection in mice. Helicobacter 2003, 8(6):613-625.
• [23]Akhiani AA, Pappo J, Kabok Z, Schon K, Gao W, Franzen LE, et al.: Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 2002, 169(12):6977-6984.
• [24]Corthesy-Theulaz IE, Hopkins S, Bachmann D, Saldinger PF, Porta N, Haas R, et al.: Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun 1998, 66(2):581-586.